# Letrozole in Uterine Leiomyosarcoma

> **NCT05649956** · PHASE2 · RECRUITING · sponsor: **GOG Foundation** · enrollment: 40 (estimated)

## Conditions studied

- Uterine Leiomyosarcoma

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT05649956
- **Lead sponsor:** GOG Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-17
- **Primary completion:** 2028-07-30
- **Final completion:** 2029-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05649956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05649956, "Letrozole in Uterine Leiomyosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05649956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*